Stocks and Investing Stocks and Investing
Thu, March 31, 2016
[ 12:00 AM ] - WOPRAI
Anthony Crowdell Initiated (AVA) at Hold and Held Target at $41 on, Mar 31st, 2016
[ 12:00 AM ] - WOPRAI
Matthew Kaplan Initiated (ARDX) at Strong Buy and Held Target at $21 on, Mar 31st, 2016
[ 12:00 AM ] - WOPRAI
Richard Davis Initiated (ADBE) at Strong Buy and Held Target at $110 on, Mar 31st, 2016
[ 12:00 AM ] - WOPRAI
Stephen Grambling Maintained (CCL) at Hold with Increased Target to $54 on, Mar 31st, 2016
[ 12:00 AM ] - WOPRAI
Brandt Montour Maintained (CCL) at Hold with Increased Target to $58 on, Mar 31st, 2016
[ 12:00 AM ] - WOPRAI
Patrick Scholes Maintained (CCL) at Strong Buy with Increased Target to $60 on, Mar 31st, 2016
[ 12:00 AM ] - WOPRAI
Mark Palmer Downgraded (SQ) to Hold on, Mar 31st, 2016
[ 12:00 AM ] - WOPRAI
Karen Short Maintained (WMT) at Hold with Increased Target to $23 on, Mar 31st, 2016
Wed, March 30, 2016
[ 12:00 AM ] - WOPRAI
Adrienne Yih Initiated (WSM) at Sell and Held Target at $23 on, Mar 30th, 2016
[ 12:00 AM ] - WOPRAI
Karen Short Maintained (WMT) at Hold with Increased Target to $23 on, Mar 30th, 2016
[ 12:00 AM ] - WOPRAI
Nandan Amladi Downgraded (VRNT) to Hold and Decreased Target to $35 on, Mar 30th, 2016
[ 12:00 AM ] - WOPRAI
Joseph Greff Maintained (WYNN) at Buy with Increased Target to $100 on, Mar 30th, 2016
[ 12:00 AM ] - WOPRAI
Mike Kelly Downgraded (SN) to Hold on, Mar 30th, 2016
[ 12:00 AM ] - WOPRAI
Drew Babin Upgraded (SUI) to Buy on, Mar 30th, 2016
[ 12:00 AM ] - WOPRAI
Christopher Turnure Maintained (ALE) at Sell with Increased Target to $54 on, Mar 30th, 2016
[ 12:00 AM ] - WOPRAI
Matthew McClintock Initiated (AAP) at Sell and Held Target at $130 on, Mar 30th, 2016
[ 12:00 AM ] - WOPRAI
Krish Sankar Upgraded (AAPL) to Buy and Increased Target to $34 on, Mar 30th, 2016
[ 12:00 AM ] - WOPRAI
Jeremy Tonet Maintained (WES) at Buy with Increased Target to $50 on, Mar 30th, 2016
[ 12:00 AM ] - WOPRAI
Jeremy Tonet Maintained (AM) at Buy with Decreased Target to $28 on, Mar 30th, 2016
[ 12:00 AM ] - WOPRAI
Eric Wold Downgraded (AMC) to Hold on, Mar 30th, 2016
Tue, March 29, 2016
[ 12:00 AM ] - WOPRAI
Itay Michaeli Downgraded (BWA) to Hold and Held Target at $37 on, Mar 29th, 2016
[ 12:00 AM ] - WOPRAI
Joseph Moore Upgraded (AMBA) to Buy and Held Target at $55 on, Mar 29th, 2016
[ 12:00 AM ] - WOPRAI
Alonso Garcia Initiated (BMA) at Hold and Held Target at $71 on, Mar 29th, 2016
[ 12:00 AM ] - WOPRAI
Ryan Tunis Maintained (AIG) at Hold with Decreased Target to $58 on, Mar 29th, 2016
[ 12:00 AM ] - WOPRAI
Atif Malik Downgraded (SWKS) to Hold and Held Target at $78 on, Mar 29th, 2016
[ 12:00 AM ] - WOPRAI
Scott Devitt Maintained (AMZN) at Strong Buy with Increased Target to $39 on, Mar 29th, 2016
[ 12:00 AM ] - WOPRAI
Stephen Grambling Maintained (CCL) at Hold with Increased Target to $53 on, Mar 29th, 2016
[ 12:00 AM ] - WOPRAI
William Stein Upgraded (ST) to Strong Buy on, Mar 29th, 2016
Mon, March 28, 2016
[ 12:00 AM ] - WOPRAI
Jason West Maintained (YUM) at Hold with Increased Target to $82 on, Mar 28th, 2016
[ 12:00 AM ] - WOPRAI
David Lebowitz Initiated (SNDX) at Buy and Held Target at $22 on, Mar 28th, 2016

David Lebowitz Initiated (SNDX) at Buy and Held Target at $22 on, Mar 28th, 2016


Published on 2024-10-25 12:03:00 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Buy and Held Target at $22 on, Mar 28th, 2016.

David, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources